Particulates and residues are key types of contamination present in the pharmaceutical industry. These may be produced from an extensive range of sources including undissolved residuals in buffer and ...

A streamlined workflow using Six Sigma's DMAIC methodology was developed to identify and mitigate visible particles in biologics, reducing time and resources while maintaining quality. Visual ...

To expose and extract coal seams buried deep under mountains, miners blast through rock with explosives in a method called mountaintop removal mining. In Appalachia where such mining is widespread, ...

The parenteral manufacturing industry is taking action to address particulate contamination issues. Particulate matter in parenteral drugs has been recognized as a risk to patients for nearly two ...

Current emissions regulations are focused on what comes out of vehicle tailpipes, but a new study claims more than half of road-vehicle particulate emissions—fine particles that can pollute ...

Residues and particulates are main types of contamination found in the pharmaceutical sector. These may be produced from a broad range of sources including undissolved residuals in buffer and media ...

A previously unknown mechanisms may explain why air pollution in the form of particulates causes heart attacks, stroke, and increasing mortality. Particulates in diesel exhaust are a substantial cause ...

The regulatory compliance standards for modern pharmaceutical products are among the harshest in the world, demanding cutting-edge quality assurance and quality control procedures to ensure that ...

Particulates make us ill, and particulates affect the climate. The direct combustion of wood and other fuels is only partially responsible for producing fine particulates – the rest evolve from a ...

If we're not going to stop climate change by reducing emissions, then we're going to have to engineer some outlandish way to save civilization—that's the basic logic behind geoengineering, which ...